Related Experiment Video
Updated: Aug 18, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Amyloid-beta peptides induce cell proliferation and macrophage colony-stimulating factor expression via the
Sachiko Ito1, Makoto Sawada, Masataka Haneda
1Department of Basic Gerontology, National Institute for Longevity Sciences, 36-3 Gengo, Morioka-cho, Obu, Aichi 474-8522, Japan.
Abstract:
Alzheimer's disease is characterized by numerous amyloid-beta peptide (Abeta) plaques surrounded by microglia. Here we report that Abeta induces the proliferation of the mouse microglial cell line Ra2 by increasing the expression of macrophage colony-stimulating factor (M-CSF). We examined signal cascades for Abeta-induced M-CSF mRNA expression. The induction of M-CSF was blocked by a phosphatidylinositol 3 kinase (PI3-kinase) inhibitor (LY294002), a Src family tyrosine kinase inhibitor (PP1) and an Akt inhibitor. Electrophoretic mobility shift assays showed that Abeta enhanced NF-kappaB binding activity to the NF-kappaB site of the mouse M-CSF promoter, which was blocked by LY294002. These results indicate that Abeta induces M-CSF mRNA expression via the PI3-kinase/Akt/NF-kappaB pathway.
Insights
Alzheimer's disease amyloid-beta peptides stimulate microglial proliferation by increasing macrophage colony-stimulating factor (M-CSF) expression. This occurs through the phosphatidylinositol 3-kinase/Akt/NF-kappaB signaling pathway.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Alzheimer's disease (AD) is marked by amyloid-beta (Abeta) plaques and microglial activation.
- Microglia play a crucial role in AD pathogenesis and neuroinflammation.
Purpose of the Study:
- To investigate the mechanism by which Abeta peptides induce microglial proliferation.
- To identify the specific signaling pathways involved in Abeta-mediated M-CSF expression.
Main Methods:
- Utilized a mouse microglial cell line (Ra2).
- Assessed M-CSF mRNA expression following Abeta treatment.
- Employed kinase inhibitors (PI3-kinase inhibitor LY294002, Src inhibitor PP1, Akt inhibitor).
- Performed electrophoretic mobility shift assays (EMSA) to evaluate NF-kappaB DNA binding activity.
Main Results:
- Abeta treatment increased M-CSF mRNA expression in Ra2 cells.
- Inhibitors of PI3-kinase, Src family kinases, and Akt blocked Abeta-induced M-CSF expression.
- Abeta enhanced NF-kappaB binding to the M-CSF promoter, an effect abolished by LY294002.
- The PI3-kinase/Akt/NF-kappaB pathway mediates Abeta-induced M-CSF expression.
Conclusions:
- Abeta peptides stimulate microglial proliferation via increased M-CSF expression.
- The signaling cascade involves PI3-kinase, Akt, and NF-kappaB activation.
- This pathway represents a potential therapeutic target for Alzheimer's disease.
Related Concept Videos
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
The Ras Gene
Ras is a superfamily...
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway

